Metraipolis › archive › dc_464fe5e91ca1

Sex-Based Differences in SGLT2i and GLP-1RA Use and Mortality in T2DM with Atherosclerotic Cardiovascular Disease — Europe PMC PMID:41751303

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41751303
DOI
10.3390/biomedicines14020404
License (as archived)
solo-consultazione
Archived
2026-11-05T23:28:55.079Z
SHA-256 of the archived text
44f0c1ae8499002f54b565f2885a4e5d624641077b77848c5982fe60714ae8d7
Stable URL of this page
https://metraipolis.com/documento/dc_464fe5e91ca1

How to cite

Sex-Based Differences in SGLT2i and GLP-1RA Use and Mortality in T2DM with Atherosclerotic Cardiovascular Disease — Europe PMC PMID:41751303 — Europe PMC (en), https://europepmc.org/article/MED/41751303 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_464fe5e91ca1 (Metraipolis archive dc_464fe5e91ca1, sha256 44f0c1ae8499002f54b565f2885a4e5d624641077b77848c5982fe60714ae8d7)
BibTeX
@misc{dc464fe5e91ca1,
  title = {Sex-Based Differences in SGLT2i and GLP-1RA Use and Mortality in T2DM with Atherosclerotic Cardiovascular Disease — Europe PMC PMID:41751303},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41751303},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_464fe5e91ca1; sha256 44f0c1ae8499002f54b565f2885a4e5d624641077b77848c5982fe60714ae8d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751303. Agents can read the archived copy with the MCP tool read_document.